Recall
FDAHealthNovember 19, 2024

Mylan Institutional, Inc. — Levothyroxine Sodium Tablets, USP, 112 mcg (0.112 mg), 100 Tablets per carton (10 unit dose blister cards of 10 tablets each), Rx only, Manufactured for: Mylan Pharmaceutic

⚠️ Subpotent and Superpotent Drug

Is this relevant to me?

Geography
Nationwide
Source agency
FDA
Category
Health
Published
November 19, 2024

Nationwide in the USA.

What's affected?

Product
Levothyroxine Sodium Tablets, USP, 112 mcg (0.112 mg), 100 Tablets per carton (10 unit dose blister cards of 10 tablets each), Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA. NDC: 42292-039-20
Lot code
3115707

Additional details

Lot #: 3115707, Exp. Date 02/2025

What should I do?

Recommended action

Class II recall. Voluntary: Firm initiated Quantity affected: 988 cartons.

View original FDA notice →

Get Health recall alerts

Delivered to your inbox. Free. No account required.